Document Detail


Developing community coalitions in youth violence prevention.
MedLine Citation:
PMID:  12355966     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Youth violence is a public health problem that needs input from physician leaders to support efforts in their communities. By forming and supporting community coalitions, physicians can advocate for both their individual patients and their community in order to prevent youth violence. In this article, we review the definition, structure, and specific issues of community collaborative efforts in the area of youth violence prevention.
Authors:
Wendi K Heuermann; Marlene D Melzer-Lange
Related Documents :
12489046 - Management of catheter-induced venous thrombosis.
10083946 - Juvenile violence.
7604486 - A simple method using hydrophilic guide wires for the difficult urethral catheterization.
15817746 - Beyond the prison paradigm: from provoking violence to preventing it by creating "anti-...
9854266 - How to study consciousness scientifically.
9589506 - The application of cognitive-behavioural therapy for depression to people with human im...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  WMJ : official publication of the State Medical Society of Wisconsin     Volume:  101     ISSN:  1098-1861     ISO Abbreviation:  WMJ     Publication Date:  2002  
Date Detail:
Created Date:  2002-10-01     Completed Date:  2002-11-08     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9716054     Medline TA:  WMJ     Country:  United States    
Other Details:
Languages:  eng     Pagination:  30-3     Citation Subset:  IM    
Affiliation:
Project Ujima, Children's Hospital of Wisconsin, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Child
Community-Institutional Relations*
Humans
Program Development
Violence / prevention & control*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A new LH-RH agonist for treatment of prostate cancer, 3-month controlled-release formulation of gose...
Next Document:  Big raises all around. Is everybody happy?